ATC code C08: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Protected "ATC code C08": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(No difference)

Revision as of 16:10, 27 September 2011

WikiDoc Resources for ATC code C08

Articles

Most recent articles on ATC code C08

Most cited articles on ATC code C08

Review articles on ATC code C08

Articles on ATC code C08 in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ATC code C08

Images of ATC code C08

Photos of ATC code C08

Podcasts & MP3s on ATC code C08

Videos on ATC code C08

Evidence Based Medicine

Cochrane Collaboration on ATC code C08

Bandolier on ATC code C08

TRIP on ATC code C08

Clinical Trials

Ongoing Trials on ATC code C08 at Clinical Trials.gov

Trial results on ATC code C08

Clinical Trials on ATC code C08 at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ATC code C08

NICE Guidance on ATC code C08

NHS PRODIGY Guidance

FDA on ATC code C08

CDC on ATC code C08

Books

Books on ATC code C08

News

ATC code C08 in the news

Be alerted to news on ATC code C08

News trends on ATC code C08

Commentary

Blogs on ATC code C08

Definitions

Definitions of ATC code C08

Patient Resources / Community

Patient resources on ATC code C08

Discussion groups on ATC code C08

Patient Handouts on ATC code C08

Directions to Hospitals Treating ATC code C08

Risk calculators and risk factors for ATC code C08

Healthcare Provider Resources

Symptoms of ATC code C08

Causes & Risk Factors for ATC code C08

Diagnostic studies for ATC code C08

Treatment of ATC code C08

Continuing Medical Education (CME)

CME Programs on ATC code C08

International

ATC code C08 en Espanol

ATC code C08 en Francais

Business

ATC code C08 in the Marketplace

Patents on ATC code C08

Experimental / Informatics

List of terms related to ATC code C08

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

A section of the Anatomical Therapeutic Chemical Classification System.

C Cardiovascular system

C08C Selective calcium channel blockers with mainly vascular effects

C08CA Dihydropyridine derivatives

C08CA01 Amlodipine
C08CA02 Felodipine
C08CA03 Isradipine
C08CA04 Nicardipine
C08CA05 Nifedipine
C08CA06 Nimodipine
C08CA07 Nisoldipine
C08CA08 Nitrendipine
C08CA09 Lacidipine
C08CA10 Nilvadipine
C08CA11 Manidipine
C08CA12 Barnidipine
C08CA13 Lercanidipine
C08CA14 Cilnidipine
C08CA15 Benidipine
C08CA55 Nifedipine, combinations

C08CX Other selective calcium channel blockers with mainly vascular effects

C08CX01 Mibefradil

C08D Selective calcium channel blockers with direct cardiac effects

C08DA Phenylalkylamine derivatives

C08DA01 Verapamil
C08DA02 Gallopamil
C08DA51 Verapamil, combinations

C08DB Benzothiazepine derivatives

C08DB01 Diltiazem

C08E Non-selective calcium channel blockers

C08EA Phenylalkylamine derivatives

C08EA01 Fendiline
C08EA02 Bepridil

C08EX Other non-selective calcium channel blockers

C08EX01 Lidoflazine
C08EX02 Perhexiline

C08G Calcium channel blockers and diuretics

C08GA Calcium channel blockers and diuretics

C08GA01 Nifedipine and diuretics

Template:SIB


Template:WikiDoc Sources